Hematology
From the Journals
Few clinical outcomes convincingly linked to sickle cell trait
The systematic review showed evidence to support sickle cell trait as a risk factor for proteinuria and chronic kidney disease.
From the Journals
Cardiovascular disease risk unchanged in men with hemophilia A
Concerns about an elevated cardiovascular disease risk in hemophilia A patients may be unfounded, a new study suggests.
Conference Coverage
Protocol violations, missed transfusions among blood delivery errors
BOSTON – Nearly one-third of transfusion errors reported by pediatric units were linked to a “this kid is special” hubris among providers,...
Conference Coverage
Need blood STAT? Call for a drone
BOSTON – Autonomous unmanned aerial vehicles bring blood to remote hospitals in Africa, but a U.S.-based system will need to overcome significant...
Feature
Tech-based cancer company raises access concerns
Oncologists say a new company that aims to link patients with cancer care and clinical trials through technology has both positives and negatives...
News
FDA approves DNA-based blood type test
This is the first molecular-based test for red blood cell types to report genotypes in its results.
From the Journals
Crizanlizumab relieves sickle cell crises across subgroups
The post hoc analysis of the SUSTAIN trial showed a significant decrease in painful vaso-occlusive crises.
Clinical Inquiries
What’s the best VTE treatment for patients with cancer?
EVIDENCE-BASED ANSWER: No head-to-head studies directly compare all the main treatments for venous thromboembolism (VTE) in cancer patients. Long-...
Applied Evidence
Strategies for caring for the well cancer survivor
Surveillance of existing cancer, management of treatment-related adverse effects, and screening for second cancers are key to the care you'll...
Conference Coverage
Antithrombotic strategy 1 year after stenting in AF patients leans toward oral anticoagulant alone
SAN DIEGO – A primary endpoint failed to show noninferiority of oral anticoagulants alone versus anticoagulants plus antiplatelet therapy, but a...
From the Journals
Coagulopathy outbreak underscores danger of synthetic cannabinoids
Four patients died after developing spontaneous intracranial bleeding.